Regulatory News
Monday, November 21, 2016
BRIEF-Sanofi says receives FDA approval of Soliqua 100/33
* Sanofi receives FDA approval of Soliqua(tm) 100/33, for
the treatment of adults with type 2 diabetes
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment